Microbiome Project Articles & Analysis
1 news found
We appreciate the support from the National Institutes of Health and North Carolina Biotechnology Center to enable Symberix to advance a new therapeutic paradigm based on pharmaceutical control of the microbiome.” “NCATS has a successful track record in small molecule tool discovery based on targets derived from the Human Genome Project, and this ...